These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24134506)

  • 1. Perceived barriers and facilitators to physical activity in men with prostate cancer: possible influence of androgen deprivation therapy.
    Keogh JW; Patel A; MacLeod RD; Masters J
    Eur J Cancer Care (Engl); 2014 Mar; 23(2):263-73. PubMed ID: 24134506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of physically active men with prostate cancer on the role of physical activity in maintaining their quality of life: possible influence of androgen deprivation therapy.
    Keogh JW; Patel A; MacLeod RD; Masters J
    Psychooncology; 2013 Dec; 22(12):2869-75. PubMed ID: 23904113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Qualitative Study Exploring the Perceptions of Sedentary Behavior in Prostate Cancer Survivors Receiving Androgen-Deprivation Therapy.
    Trinh L; Arbour-Nicitopoulos KP; Sabiston CM; Alibhai SM; Jones JM; Berry SR; Loblaw A; Faulkner GE
    Oncol Nurs Forum; 2015 Jul; 42(4):398-406. PubMed ID: 26148319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study.
    Hansen PA; Dechet CB; Porucznik CA; LaStayo PC
    PM R; 2009 Nov; 1(11):1019-24. PubMed ID: 19942188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing androgen-deprivation therapy.
    Keogh JW; Shepherd D; Krägeloh CU; Ryan C; Masters J; Shepherd G; MacLeod R
    N Z Med J; 2010 Nov; 123(1325):20-9. PubMed ID: 21317957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise as a supportive care strategy in men with prostate cancer receiving androgen deprivation therapy at a regional cancer centre: a survey of patients and clinicians.
    Elbourne H; Soo WK; O'Reilly V; Moran A; Steer CB
    Support Care Cancer; 2022 Feb; 30(2):1379-1389. PubMed ID: 34519868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lived experience of physically active older prostate cancer survivors on androgen deprivation therapy.
    Wright-St Clair VA; Malcolm W; Keogh JW
    Aging Male; 2014 Mar; 17(1):57-62. PubMed ID: 23862577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer.
    Segal RJ; Reid RD; Courneya KS; Malone SC; Parliament MB; Scott CG; Venner PM; Quinney HA; Jones LW; D'Angelo ME; Wells GA
    J Clin Oncol; 2003 May; 21(9):1653-9. PubMed ID: 12721238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Information needs of men on androgen deprivation therapy.
    Soeyonggo T; Warde P; Fleshner N; Timilshina N; Alibhai SM
    BJU Int; 2012 May; 109(10):1503-9. PubMed ID: 21883845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review.
    Bylow K; Mohile SG; Stadler WM; Dale W
    Cancer; 2007 Dec; 110(12):2604-13. PubMed ID: 17960609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
    Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs.
    Kyrdalen AE; Dahl AA; Hernes E; Hem E; Fosså SD
    Prostate; 2010 Sep; 70(13):1480-9. PubMed ID: 20687221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deprivation therapy: evidence-based management of side effects.
    Ahmadi H; Daneshmand S
    BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ; Hammett J; Malcolm JB; Judge BA; Womack JH; Kincade MC; Ogles ML; Mancini JG; Patterson AL; Wake RW; Derweesh IH
    Can J Urol; 2008 Oct; 15(5):4249-56; discussion 4256. PubMed ID: 18814813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical function in men with prostate cancer on androgen deprivation therapy.
    Clay CA; Perera S; Wagner JM; Miller ME; Nelson JB; Greenspan SL
    Phys Ther; 2007 Oct; 87(10):1325-33. PubMed ID: 17684084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.
    Sadetsky N; Greene K; Cooperberg MR; Hubbard A; Carroll PR; Satariano W
    Cancer; 2011 Oct; 117(19):4406-13. PubMed ID: 21412760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy.
    Chipperfield K; Fletcher J; Millar J; Brooker J; Smith R; Frydenberg M; Burney S
    Psychooncology; 2013 Oct; 22(10):2169-76. PubMed ID: 23483679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study.
    Pirl WF; Siegel GI; Goode MJ; Smith MR
    Psychooncology; 2002; 11(6):518-23. PubMed ID: 12476433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.